Clindamycin alcoholate (CAS No 58207-19-5) is a derivative of the antibiotic clindamycin primarily utilized in biomedical research focused on antimicrobial activity It originates from the parent compound clindamycin a lincosamide antibiotic sourced from Streptomyces lincolnensis Its mechanism of action involves binding to the 50S subunit of the bacterial ribosome thereby inhibiting protein synthesis and exhibiting bacteriostatic effects The compound demonstrates common in vitro activity in the nanomolar to low micromolar range displaying efficacy against various Gram-positive bacteria Typical applications include testing in cell models and animal studies often utilized in drug screening assays to evaluate antibacterial potential Experimental concentrations typically depend on the specific research design ensuring applicability across different experimental setups